Cargando…
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
BACKGROUND: Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system characterized by demyelination, neuroinflammation, and neurodegeneration. Activation of the kynurenine pathway (KP) results from acute and chronic neuroinflammation leading to both immune suppress...
Autores principales: | Sundaram, Gayathri, Lim, Chai K., Brew, Bruce J., Guillemin, Gilles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276083/ https://www.ncbi.nlm.nih.gov/pubmed/32505212 http://dx.doi.org/10.1186/s12974-020-01844-y |
Ejemplares similares
-
Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease
por: Sundaram, Gayathri, et al.
Publicado: (2022) -
Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
por: Lim, Chai K., et al.
Publicado: (2010) -
Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
por: Adams, Seray, et al.
Publicado: (2014) -
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
por: Lovelace, Michael D., et al.
Publicado: (2016) -
Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease
por: Jones, Simon P., et al.
Publicado: (2015)